SCHEMBL1634970

SCHEMBL1634970

CC(C)(C)c1ccccc1N=Cc1ccc2cccc(O)c2n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.66
ALDH1A1 P00352 2/20 0.66
PLA2G1B P04054 1/20 0.66
ATG4B Q9Y4P1 1/20 0.66
KDM4E B2RXH2 5/20 0.56
POLB P06746 1/20 0.46
KMT2A Q03164 10/20 0.45
LMNA P02545 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
MEN1 O00255 9/20 0.43
NPC1 O15118 9/20 0.43
RAB9A P51151 6/20 0.43
HSP90AA1 P07900 3/20 0.43
AGTR1 P30556 3/20 0.43
CD74 P04233 1/20 0.43
MIF P14174 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 2/20 0.41
PKM P14618 1/20 0.41
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12725749 1.00 MAPT (0.66) MAPTALDH1A1PLA2G1BATG4BKDM4E
SCHEMBL12725753 0.81 KDM4E (0.61) MAPTALDH1A1KDM4EPOLBKMT2A
SCHEMBL1635307 0.81 KDM4E (0.61) MAPTALDH1A1KDM4EPOLBKMT2A
SCHEMBL16077906 0.80 ALDH1A1 (0.70) MAPTALDH1A1PLA2G1BATG4BKDM4E
SCHEMBL1635902 0.76 KDM4E (0.67) MAPTALDH1A1KDM4EPOLBKMT2A
SCHEMBL12725750 0.76 KDM4E (0.67) MAPTALDH1A1KDM4EPOLBKMT2A
SCHEMBL23335111 0.76 KDM4E (0.67) MAPTALDH1A1KDM4EPOLBKMT2A
SCHEMBL1634513 0.74 KDM4E (0.63) MAPTALDH1A1KDM4EPOLBKMT2A
SCHEMBL12725741 0.74 KDM4E (0.63) MAPTALDH1A1KDM4EPOLBKMT2A
SCHEMBL6721105 0.74 KDM4E (0.77) MAPTALDH1A1KDM4EPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932331-B2 Polymerisation of ethylene and α-olefins with imino-quinolinol complexes TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2011-04-26 US disclosed
EP-1994006-B1 POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH IMINO-QUINOLINOL COMPLEXES TOTAL PETROCHEMICALS RES FELUY (BE) 2010-11-17 EP disclosed
US-20100004411-A1 POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH IMINO-QUINOLINOL COMPLEXES TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-01-07 US disclosed
EP-1832579-A1 Polymerisation of ethylene and alpha-olefins with imino-quinolinol complexes TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2007-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004411-A1 POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH IMINO-QUINOLINOL COMPLEXES UBE2L3, PCNA, UBE2L6 MAPT 1104/4885ALDH1A1 2024/4885PLA2G1B 3227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.